Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trimetazidine in ATTRwt Cardiac Amyloidosis
NCT05633563Phase 4Completed
- Start
- Oct 2021
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of trimetazidine in wild-type transthyretin amyloidosis (ATTRwt). Started Oct 2021; status: completed.
02
Drugs
trimetazidine
03
Conditions
wild-type transthyretin amyloidosis (ATTRwt)
Beyond the preview
Go deeper on NCT05633563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05633563.